Browse HCPCS Level II 2020 Edition

HCPCS Level II Table of Contents

C8957 - C9497  Drugs and Biologicals

C8957
Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
shortProlonged iv inf, req pump
MUE
LocationValueAjudication IndicatorRationale
PRA2.03 Date of Service Edit: ClinicalCMS Policy
OPH2.03 Date of Service Edit: ClinicalCMS Policy
C9014
Injection, cerliponase alfa, 1 mg
shortInjection, cerliponase alfa
C9015
Injection, c-1 esterase inhibitor (human), haegarda, 10 units
shortC-1 esterase, haegarda
C9016
Injection, triptorelin extended release, 3.75 mg
shortInj, triptorelin ext rel
C9021
Injection, obinutuzumab, 10 mg
shortInjection, obinutuzumab
C9022
Injection, elosulfase alfa, 1mg
shortInjection, elosulfase alfa
C9023
Injection, testosterone undecanoate, 1 mg
shortInj testosterone undecanoate
C9024
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
shortInj, daunorubicin-cytarabine
C9025
Injection, ramucirumab, 5 mg
shortInjection, ramucirumab
C9026
Injection, vedolizumab, 1 mg
shortInjection, vedolizumab
C9027
Injection, pembrolizumab, 1 mg
shortInjection, pembrolizumab
C9028
Injection, inotuzumab ozogamicin, 0.1 mg
shortInj. inotuzumab ozogamicin
C9029
Injection, guselkumab, 1 mg
shortInjection, guselkumab
C9030
Injection, copanlisib, 1 mg
shortInj copanlisib
C9031
Lutetium lu 177, dotatate, therapeutic, 1 mci
shortLutetium lu 177 dotatate, tx
C9032
Injection, voretigene neparvovec-rzyl, 1 billion vector genome
shortVoretigene neparvovec-rzyl
C9033
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
shortInj, akynzeo
C9034
Injection, dexamethasone 9%, intraocular, 1 mcg
shortInjection, dexamethasone 9%
C9035
Injection, aripiprazole lauroxil (aristada initio), 1 mg
shortInjection, aristada initio
C9036
Injection, patisiran, 0.1 mg
shortInjection, patisiran
C9037
Injection, risperidone (perseris), 0.5 mg
shortInjection, risperidone
C9038
Injection, mogamulizumab-kpkc, 1 mg
shortInj mogamulizumab-kpkc
C9039
Injection, plazomicin, 5 mg
shortInjection, plazomicin
C9040
Injection, fremanezumab-vfrm, 1mg
shortInjection, fremanezumab-vfrm
C9041
Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
shortInj, coagulation factor xa
MUE
LocationValueAjudication IndicatorRationale
PRA180.03 Date of Service Edit: ClinicalCMS Policy
OPH180.03 Date of Service Edit: ClinicalCMS Policy
C9042
Injection, bendamustine hcl (belrapzo), 1 mg
shortInj., belrapzo 1 mg
C9043
Injection, levoleucovorin, 1 mg
shortInjection, levoleucovorin
C9044
Injection, cemiplimab-rwlc, 1 mg
shortInjection, cemiplimab-rwlc
C9045
Injection, moxetumomab pasudotox-tdfk, 0.01 mg
shortMoxetumomab pasudotox-tdfk
C9046
Cocaine hydrochloride nasal solution for topical administration, 1 mg
shortCocaine hcl nasal solution
MUE
LocationValueAjudication IndicatorRationale
PRA160.03 Date of Service Edit: ClinicalPrescribing Information
OPH160.03 Date of Service Edit: ClinicalPrescribing Information
C9047
Injection, caplacizumab-yhdp, 1 mg
shortInjection, caplacizumab-yhdp
C9048
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
shortDexamethasone ophth insert
C9049
Injection, tagraxofusp-erzs, 10 mcg
shortInjection, tagraxofusp-erzs
C9050
Injection, emapalumab-lzsg, 1 mg
shortInjection, emapalumab-lzsg
C9051
Injection, omadacycline, 1 mg
shortInjection, omadacycline
C9052
Injection, ravulizumab-cwvz, 10 mg
shortInjection, ravulizumab-cwv
C9054
Injection, lefamulin (xenleta), 1 mg
shortInjection, lefamulin
C9055
Injection, brexanolone, 1mg
shortInj, brexanolone
C9113
Injection, pantoprazole sodium, per vial
shortInj pantoprazole sodium, via
MUE
LocationValueAjudication IndicatorRationale
PRA10.03 Date of Service Edit: ClinicalClinical: CMS Workgroup
OPH10.03 Date of Service Edit: ClinicalClinical: Data
C9121
Injection, argatroban, per 5 mg
shortInjection, argatroban
C9132
Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
shortKcentra, per i.u.
MUE
LocationValueAjudication IndicatorRationale
PRA5500.03 Date of Service Edit: ClinicalPrescribing Information
OPH5500.03 Date of Service Edit: ClinicalPrescribing Information
C9133
Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
shortFactor ix recombinant
C9134
Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
shortFactor xiii a-subunit recomb
C9135
Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
shortFactor ix (alprolix)
C9136
Injection, factor viii, fc fusion protein, (recombinant), per i.u.
shortFactor viii (eloctate)
C9137
Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
shortAdynovate factor viii recom
C9138
Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
shortNuwiq factor viii recomb
C9139
Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
shortIdelvion, 1 i.u.
C9140
Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
shortAfstyla factor viii recomb
C9141
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
shortFactor viii pegylated-aucl
C9248
Injection, clevidipine butyrate, 1 mg
shortInj, clevidipine butyrate
MUE
LocationValueAjudication IndicatorRationale
PRA25.03 Date of Service Edit: ClinicalClinical: CMS Workgroup
OPH25.03 Date of Service Edit: ClinicalClinical: Data
C9250
Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
shortArtiss fibrin sealant
MUE
LocationValueAjudication IndicatorRationale
PRA1.03 Date of Service Edit: ClinicalClinical: Data
OPH5.03 Date of Service Edit: ClinicalClinical: Data
C9254
Injection, lacosamide, 1 mg
shortInjection, lacosamide
MUE
LocationValueAjudication IndicatorRationale
PRA400.03 Date of Service Edit: ClinicalClinical: CMS Workgroup
OPH400.03 Date of Service Edit: ClinicalPrescribing Information
C9257
Injection, bevacizumab, 0.25 mg
shortBevacizumab injection
MUE
LocationValueAjudication IndicatorRationale
PRA5.03 Date of Service Edit: ClinicalPrescribing Information
OPH8000.03 Date of Service Edit: ClinicalClinical: Data
C9275
Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
shortHexaminolevulinate hcl
C9285
Lidocaine 70 mg/tetracaine 70 mg, per patch
shortPatch, lidocaine/tetracaine
MUE
LocationValueAjudication IndicatorRationale
PRA2.03 Date of Service Edit: ClinicalPrescribing Information
OPH2.03 Date of Service Edit: ClinicalPrescribing Information
C9290
Injection, bupivacaine liposome, 1 mg
shortInj, bupivacaine liposome
MUE
LocationValueAjudication IndicatorRationale
PRA266.03 Date of Service Edit: ClinicalPrescribing Information
OPH266.03 Date of Service Edit: ClinicalPrescribing Information
C9293
Injection, glucarpidase, 10 units
shortInjection, glucarpidase
MUE
LocationValueAjudication IndicatorRationale
PRA700.03 Date of Service Edit: ClinicalPrescribing Information
OPH700.03 Date of Service Edit: ClinicalPrescribing Information
C9349
Puraply, and puraply antimicrobial, any type, per square centimeter
shortPuraply, puraply antimic
C9352
Microporous collagen implantable tube (neuragen nerve guide), per centimeter length
shortNeuragen nerve guide, per cm
MUE
LocationValueAjudication IndicatorRationale
PRA3.03 Date of Service Edit: ClinicalPrescribing Information
OPH3.03 Date of Service Edit: ClinicalPrescribing Information
C9353
Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length
shortNeurawrap nerve protector,cm
MUE
LocationValueAjudication IndicatorRationale
PRA4.03 Date of Service Edit: ClinicalPrescribing Information
OPH4.03 Date of Service Edit: ClinicalPrescribing Information
C9354
Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
shortVeritas collagen matrix, cm2
MUE
LocationValueAjudication IndicatorRationale
PRA300.03 Date of Service Edit: ClinicalPrescribing Information
OPH300.03 Date of Service Edit: ClinicalPrescribing Information
C9355
Collagen nerve cuff (neuromatrix), per 0.5 centimeter length
shortNeuromatrix nerve cuff, cm
MUE
LocationValueAjudication IndicatorRationale
PRA3.03 Date of Service Edit: ClinicalPrescribing Information
OPH3.03 Date of Service Edit: ClinicalPrescribing Information
C9356
Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
shortTenoglide tendon prot, cm2
MUE
LocationValueAjudication IndicatorRationale
PRA125.03 Date of Service Edit: ClinicalPrescribing Information
OPH125.03 Date of Service Edit: ClinicalPrescribing Information
C9358
Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
shortSurgimend, fetal
MUE
LocationValueAjudication IndicatorRationale
PRA800.03 Date of Service Edit: ClinicalClinical: Data
OPH800.03 Date of Service Edit: ClinicalClinical: Data
C9359
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc
shortImplnt,bon void filler-putty
MUE
LocationValueAjudication IndicatorRationale
PRA30.03 Date of Service Edit: ClinicalPrescribing Information
OPH30.03 Date of Service Edit: ClinicalPrescribing Information
C9360
Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
shortSurgimend, neonatal
MUE
LocationValueAjudication IndicatorRationale
PRA300.03 Date of Service Edit: ClinicalClinical: Data
OPH300.03 Date of Service Edit: ClinicalClinical: Data
C9361
Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length
shortNeuromend nerve wrap
MUE
LocationValueAjudication IndicatorRationale
PRA10.03 Date of Service Edit: ClinicalPrescribing Information
OPH10.03 Date of Service Edit: ClinicalPrescribing Information
C9362
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc
shortImplnt,bon void filler-strip
MUE
LocationValueAjudication IndicatorRationale
PRA60.03 Date of Service Edit: ClinicalClinical: Data
OPH60.03 Date of Service Edit: ClinicalClinical: Data
C9363
Skin substitute, integra meshed bilayer wound matrix, per square centimeter
shortIntegra meshed bil wound mat
MUE
LocationValueAjudication IndicatorRationale
PRA500.03 Date of Service Edit: ClinicalClinical: Data
OPH500.03 Date of Service Edit: ClinicalClinical: Data
C9364
Porcine implant, permacol, per square centimeter
shortPorcine implant, permacol
MUE
LocationValueAjudication IndicatorRationale
PRA600.03 Date of Service Edit: ClinicalClinical: Data
OPH600.03 Date of Service Edit: ClinicalClinical: Data
C9399
Unclassified drugs or biologicals
shortUnclassified drugs or biolog
C9407
Iodine i-131 iobenguane, diagnostic, 1 millicurie
shortIodine i-131 iobenguane, dx
C9408
Iodine i-131 iobenguane, therapeutic, 1 millicurie
shortIodine i-131 iobenguane, tx
C9441
Injection, ferric carboxymaltose, 1 mg
shortInj, ferric carboxymaltose
C9442
Injection, belinostat, 10 mg
shortInjection, belinostat
C9443
Injection, dalbavancin, 10 mg
shortInjection, dalbavancin
C9444
Injection, oritavancin, 10 mg
shortInjection, oritavancin
C9445
Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units
shortC-1 esterase, ruconest
C9446
Injection, tedizolid phosphate, 1 mg
shortInj, tedizolid phosphate
C9447
Injection, phenylephrine and ketorolac, 4 ml vial
shortInj, phenylephrine ketorolac
C9448
Netupitant 300 mg and palonosetron 0.5 mg, oral
shortOral netupitant palonosetron
C9449
Injection, blinatumomab, 1 mcg
shortInj, blinatumomab
C9450
Injection, fluocinolone acetonide intravitreal implant, 0.01 mg
shortFluocinolone acetonide implt
C9451
Injection, peramivir, 1 mg
shortInjection, peramivir
C9452
Injection, ceftolozane 50 mg and tazobactam 25 mg
shortInj, ceftolozane/tazobactam
C9453
Injection, nivolumab, 1 mg
shortInjection, nivolumab
C9454
Injection, pasireotide long acting, 1 mg
shortInj, pasireotide long acting
C9455
Injection, siltuximab, 10 mg
shortInjection, siltuximab
C9456
Injection, isavuconazonium sulfate, 1 mg
shortInj, isavuconazonium sulfate
C9457
Injection, sulfur hexafluoride lipid microsphere, per ml
shortLumason contrast agent
C9458
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
shortFlorbetaben f18
C9459
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
shortFlutemetamol f18
C9460
Injection, cangrelor, 1 mg
shortInjection, cangrelor
MUE
LocationValueAjudication IndicatorRationale
PRA1.03 Date of Service Edit: ClinicalClinical: CMS Workgroup
OPH100.03 Date of Service Edit: ClinicalPrescribing Information
C9461
Choline c 11, diagnostic, per study dose
shortCholine c 11, diagnostic
C9462
Injection, delafloxacin, 1 mg
shortInjection, delafloxacin
MUE
LocationValueAjudication IndicatorRationale
PRA600.03 Date of Service Edit: ClinicalPrescribing Information
OPH600.03 Date of Service Edit: ClinicalPrescribing Information
C9463
Injection, aprepitant, 1 mg
shortInjection, aprepitant
C9464
Injection, rolapitant, 0.5 mg
shortInjection, rolapitant
C9465
Hyaluronan or derivative, durolane, for intra-articular injection, per dose
shortInjection, durolane
C9466
Injection, benralizumab, 1 mg
shortInjection, benralizumab
C9467
Injection, rituximab and hyaluronidase, 10 mg
shortInj rituximab hyaluronidase
C9468
Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.
shortInj, factor ix, rebinyn
C9469
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
shortInj triamcinolone acetonide
C9470
Injection, aripiprazole lauroxil, 1 mg
shortAripiprazole lauroxil im
C9471
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
shortHymovis, 1 mg
C9472
Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)
shortInj talimogene laherparepvec
C9473
Injection, mepolizumab, 1 mg
shortInjection, mepolizumab
C9474
Injection, irinotecan liposome, 1 mg
shortInj, irinotecan liposome
C9475
Injection, necitumumab, 1 mg
shortInjection, necitumumab
C9476
Injection, daratumumab, 10 mg
shortInjection, daratumumab
C9477
Injection, elotuzumab, 1 mg
shortInjection, elotuzumab
C9478
Injection, sebelipase alfa, 1 mg
shortInjection, sebelipase alfa
C9479
Instillation, ciprofloxacin otic suspension, 6 mg
shortInstill, ciprofloxacin otic
C9480
Injection, trabectedin, 0.1 mg
shortInjection, trabectedin
C9481
Injection, reslizumab, 1 mg
shortInjection, reslizumab
C9482
Injection, sotalol hydrochloride, 1 mg
shortSotalol hydrochloride iv
MUE
LocationValueAjudication IndicatorRationale
PRA150.03 Date of Service Edit: ClinicalPrescribing Information
OPH300.03 Date of Service Edit: ClinicalPrescribing Information
C9483
Injection, atezolizumab, 10 mg
shortInjection, atezolizumab
C9484
Injection, eteplirsen, 10 mg
shortInjection, eteplirsen
C9485
Injection, olaratumab, 10 mg
shortInjection, olaratumab
C9486
Injection, granisetron extended release, 0.1 mg
shortInj, granisetron ext
C9487
Ustekinumab, for intravenous injection, 1 mg
shortUstekinumab iv inj, 1 mg
C9488
Injection, conivaptan hydrochloride, 1 mg
shortConivaptan hcl
MUE
LocationValueAjudication IndicatorRationale
PRA20.03 Date of Service Edit: ClinicalPrescribing Information
OPH40.03 Date of Service Edit: ClinicalPrescribing Information
C9489
Injection, nusinersen, 0.1 mg
shortInjection, nusinersen
C9490
Injection, bezlotoxumab, 10 mg
shortInjection, bezlotoxumab
C9491
Injection, avelumab, 10 mg
shortInjection, avelumab
C9492
Injection, durvalumab, 10 mg
shortInjection, durvalumab
C9493
Injection, edaravone, 1 mg
shortInjection, edaravone
C9494
Injection, ocrelizumab, 1 mg
shortInjection, ocrelizumab
C9497
Loxapine, inhalation powder, 10 mg
shortLoxapine, inhalation powder